Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$69.73 - $142.9 $274,457 - $562,454
-3,936 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$134.56 - $217.97 $58,668 - $95,034
-436 Reduced 9.97%
3,936 $563,000
Q3 2021

Nov 12, 2021

SELL
$177.8 - $270.58 $306,349 - $466,209
-1,723 Reduced 28.27%
4,372 $906,000
Q2 2021

Aug 13, 2021

BUY
$121.0 - $257.67 $263,054 - $560,174
2,174 Added 55.45%
6,095 $1.29 Million
Q1 2021

May 14, 2021

BUY
$112.98 - $319.93 $442,994 - $1.25 Million
3,921 New
3,921 $711,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.